215 related articles for article (PubMed ID: 22539598)
1. Pro- and antiatherogenic effects of a dominant-negative P465L mutation of peroxisome proliferator-activated receptor-γ in apolipoprotein E-Null mice.
Pendse AA; Johnson LA; Kim HS; McNair M; Nipp CT; Wilhelm C; Maeda N
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1436-44. PubMed ID: 22539598
[TBL] [Abstract][Full Text] [Related]
2. Mediator 1 Is Atherosclerosis Protective by Regulating Macrophage Polarization.
Bai L; Li Z; Li Q; Guan H; Zhao S; Liu R; Wang R; Zhang J; Jia Y; Fan J; Wang N; Reddy JK; Shyy JY; Liu E
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1470-1481. PubMed ID: 28642237
[TBL] [Abstract][Full Text] [Related]
3. A growth hormone-releasing peptide that binds scavenger receptor CD36 and ghrelin receptor up-regulates sterol transporters and cholesterol efflux in macrophages through a peroxisome proliferator-activated receptor gamma-dependent pathway.
Avallone R; Demers A; Rodrigue-Way A; Bujold K; Harb D; Anghel S; Wahli W; Marleau S; Ong H; Tremblay A
Mol Endocrinol; 2006 Dec; 20(12):3165-78. PubMed ID: 16959872
[TBL] [Abstract][Full Text] [Related]
4. Nifedipine induces peroxisome proliferator-activated receptor-gamma activation in macrophages and suppresses the progression of atherosclerosis in apolipoprotein E-deficient mice.
Ishii N; Matsumura T; Kinoshita H; Fukuda K; Motoshima H; Senokuchi T; Nakao S; Tsutsumi A; Kim-Mitsuyama S; Kawada T; Takeya M; Miyamura N; Nishikawa T; Araki E
Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1598-605. PubMed ID: 20508203
[TBL] [Abstract][Full Text] [Related]
5. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
[TBL] [Abstract][Full Text] [Related]
6. Calpain inhibitor prevents atherosclerosis in apolipoprotein E knockout mice by regulating mRNA expression of genes related to cholesterol uptake and efflux.
Liu J; Wang Q; Wei Y; Zhang S; Chai E; Tang F
Microvasc Res; 2022 Mar; 140():104276. PubMed ID: 34742813
[TBL] [Abstract][Full Text] [Related]
7. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions.
Marleau S; Harb D; Bujold K; Avallone R; Iken K; Wang Y; Demers A; Sirois MG; Febbraio M; Silverstein RL; Tremblay A; Ong H
FASEB J; 2005 Nov; 19(13):1869-71. PubMed ID: 16123174
[TBL] [Abstract][Full Text] [Related]
8. CD36-mediated cholesterol efflux is associated with PPARgamma activation via a MAPK-dependent COX-2 pathway in macrophages.
Bujold K; Rhainds D; Jossart C; Febbraio M; Marleau S; Ong H
Cardiovasc Res; 2009 Aug; 83(3):457-64. PubMed ID: 19377069
[TBL] [Abstract][Full Text] [Related]
9. AIP1 suppresses atherosclerosis by limiting hyperlipidemia-induced inflammation and vascular endothelial dysfunction.
Huang Q; Qin L; Dai S; Zhang H; Pasula S; Zhou H; Chen H; Min W
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):795-804. PubMed ID: 23413429
[TBL] [Abstract][Full Text] [Related]
10. Lack of association between adiponectin levels and atherosclerosis in mice.
Nawrocki AR; Hofmann SM; Teupser D; Basford JE; Durand JL; Jelicks LA; Woo CW; Kuriakose G; Factor SM; Tanowitz HB; Hui DY; Tabas I; Scherer PE
Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1159-65. PubMed ID: 20299691
[TBL] [Abstract][Full Text] [Related]
11. Downregulations of CD36 and Calpain-1, Inflammation, and Atherosclerosis by Simvastatin in Apolipoprotein E Knockout Mice.
Yin M; Liu Q; Yu L; Yang Y; Lu M; Wang H; Luo D; Rong X; Tang F; Guo J
J Vasc Res; 2017; 54(3):123-130. PubMed ID: 28448973
[TBL] [Abstract][Full Text] [Related]
12. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
[TBL] [Abstract][Full Text] [Related]
13. NF-E2-related factor 2 promotes atherosclerosis by effects on plasma lipoproteins and cholesterol transport that overshadow antioxidant protection.
Barajas B; Che N; Yin F; Rowshanrad A; Orozco LD; Gong KW; Wang X; Castellani LW; Reue K; Lusis AJ; Araujo JA
Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):58-66. PubMed ID: 20947826
[TBL] [Abstract][Full Text] [Related]
14. Pparg-P465L mutation worsens hyperglycemia in Ins2-Akita female mice via adipose-specific insulin resistance and storage dysfunction.
Pendse AA; Johnson LA; Tsai YS; Maeda N
Diabetes; 2010 Nov; 59(11):2890-7. PubMed ID: 20724579
[TBL] [Abstract][Full Text] [Related]
15. Fibromodulin deficiency reduces low-density lipoprotein accumulation in atherosclerotic plaques in apolipoprotein E-null mice.
Shami A; Gustafsson R; Kalamajski S; Krams R; Segers D; Rauch U; Roos G; Nilsson J; Oldberg Å; Hultgårdh-Nilsson A
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):354-61. PubMed ID: 23202368
[TBL] [Abstract][Full Text] [Related]
16. Isoliquiritigenin Attenuates Atherogenesis in Apolipoprotein E-Deficient Mice.
Du F; Gesang Q; Cao J; Qian M; Ma L; Wu D; Yu H
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869741
[TBL] [Abstract][Full Text] [Related]
17. Vav Guanine nucleotide exchange factors regulate atherosclerotic lesion development in mice.
Rahaman SO; Li W; Silverstein RL
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2053-7. PubMed ID: 23825362
[TBL] [Abstract][Full Text] [Related]
18. Chronic infusion of salusin-alpha and -beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice.
Nagashima M; Watanabe T; Shiraishi Y; Morita R; Terasaki M; Arita S; Hongo S; Sato K; Shichiri M; Miyazaki A; Hirano T
Atherosclerosis; 2010 Sep; 212(1):70-7. PubMed ID: 20684826
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
Sontag TJ; Krishack PA; Lukens JR; Bhanvadia CV; Getz GS; Reardon CA
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):262-9. PubMed ID: 24334873
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen: A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)γ-DEPENDENT MECHANISM.
Yu M; Jiang M; Chen Y; Zhang S; Zhang W; Yang X; Li X; Li Y; Duan S; Han J; Duan Y
J Biol Chem; 2016 Aug; 291(33):16977-89. PubMed ID: 27358406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
